IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program
CAMBRIDGE, Mass.and PERTH, Australia, June 28, 2022 /PRNewswire/ —
The Functional Neuroscience Institute, a leading treatment and rehabilitation center using the latest neuroplasticity research technologies, and MetaCell, an innovative life science software company specializing in cutting-edge research software for major pharmaceutical, biotechnology and academic institutions, have joined forces to launch Neurological IFN. This application will help clinicians better serve patients with neurological disorders and provide treatments in the field of functional neuroscience. The app was tested with a limited number of clinics in 2021/2022, and is now available to clinics and patients around the world.
IFN Neurologic is an innovative application to help clinicians better serve patients with neurological disorders and provide treatments in the field of functional neuroscience
Affiliated clinics will for the first time use IFN Neurologic to perform restorative neuroplasticity procedures on their patients in their own clinic. The Affiliate program includes a comprehensive IFN (Institute of Functional Neuroscience) and AICN (Australian Institute of Clinical Neuroscience) accredited training program, all necessary hardware/software and access to the IFN Neurologic platform.
dr. Randy BeckPhD, Director of the IFN, said, “We are thrilled to launch this new application in partnership with MetaCell. With this new software that requires no installation and is accessible from any web browser globally, we now have the ability to rapidly increase our diagnostic processes and reach more patients worldwide with the click of a button.”
Giovanni Idili, COO of MetaCell, added, “We are very proud to be working with Dr. Beck and providing IFN with a solution that ultimately enables the organization to help more patients with the same level of exceptional service, and we are We look forward to partnering with many other innovative clinics using our unique approach to custom software development in concert with our clinical neuroscience platforms.”
About the NFI
The Institute of Functional Neurosciences (IFN) uses the latest research in neuroplasticity and neuroscience to develop treatment approaches aimed at improving the performance of the brain and nervous system of patients with a wide range of conditions, including migraines, seizure disorders, strokes , attention deficit disorder, obsessive compulsive disorder, developmental coordination delay, vertigo, depression, learning and developmental disabilities, concussion syndromes and autism.
MetaCell is a life science-focused software company comprised of scientists and software engineers, with deep expertise in computational neuroscience, molecular biology, data science and online software development enterprise level. Their solutions have been trusted for over a decade by some of the world’s largest pharmaceutical companies and leading research institutes in the UNITED STATESUK, Australia, Canadaand Europeincluding Biogen, Pfizer, Eisai, Salk, UCL, Mount Sinai, UCSD, Yale, Princetonand much more.
Neurological IFN: https://ifneurologique.com/ | +61 (08) 6254 2282 | firstname.lastname@example.org
NFI: https://ifn.net.au | +61 (08) 6254 2282 | email@example.com
Metacell: https://metacell.us/ | USA +1 617-286-4832 | UK +44 1865 648684 | firstname.lastname@example.org